Skip to content

Clinical trials

Terminated Phase 2 Kidney Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Neoplasms Phase: Phase 2 Status: Terminated Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20044
20052
20062
20073
20084
20091
20104
20113
20125
20131
20152
20161
20171
20182
20201
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
M.D. Anderson Cancer Center2
Medical University of South Carolina2
National Institutes of Health Clinical Center (CC)2
Rutgers, The State University of New Jersey2
University of Wisconsin, Madison2
Accelerated Community Oncology Research Network1
Agenus Inc.1
Argos Therapeutics1
Asan Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Neoplasms46
Carcinoma, Renal Cell31
Melanoma5
Neoplasm Metastasis5
Neoplasms5
Colorectal Neoplasms4
Ovarian Neoplasms4
Breast Neoplasms3
Prostatic Neoplasms3
Carcinoma, Non-Small-Cell Lung2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.